Prudential Financial Inc. decreased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 243,966 shares of the company's stock after selling 32,006 shares during the period. Prudential Financial Inc. owned 0.05% of GE HealthCare Technologies worth $19,073,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of GEHC. Sound Shore Management Inc. CT grew its stake in GE HealthCare Technologies by 2.5% in the fourth quarter. Sound Shore Management Inc. CT now owns 775,341 shares of the company's stock valued at $60,616,000 after purchasing an additional 19,208 shares in the last quarter. United Services Automobile Association acquired a new stake in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $801,000. Congress Wealth Management LLC DE grew its stake in shares of GE HealthCare Technologies by 35.0% in the fourth quarter. Congress Wealth Management LLC DE now owns 3,592 shares of the company's stock valued at $281,000 after buying an additional 932 shares in the last quarter. Vanguard Group Inc. increased its holdings in GE HealthCare Technologies by 4.3% during the fourth quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock worth $4,107,378,000 after buying an additional 2,155,429 shares during the last quarter. Finally, Stevens Capital Management LP bought a new stake in GE HealthCare Technologies during the fourth quarter worth $664,000. Institutional investors and hedge funds own 82.06% of the company's stock.
GE HealthCare Technologies Stock Performance
NASDAQ GEHC traded up $0.70 on Monday, reaching $80.71. The stock had a trading volume of 4,151,176 shares, compared to its average volume of 2,938,522. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. The company has a market cap of $36.91 billion, a P/E ratio of 18.64, a price-to-earnings-growth ratio of 3.19 and a beta of 1.13. The firm has a fifty day moving average of $86.62 and a two-hundred day moving average of $85.81. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.
GE HealthCare Technologies Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.17%. GE HealthCare Technologies's dividend payout ratio is presently 3.23%.
Wall Street Analysts Forecast Growth
A number of brokerages have recently commented on GEHC. Citigroup lifted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a "buy" rating in a research report on Thursday, February 13th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. Jefferies Financial Group upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating and upped their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. One analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and an average target price of $98.75.
Get Our Latest Report on GE HealthCare Technologies
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.
Featured Articles
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
